Driving a Cure for Cavernous Malformation. Join us.

By whatever name you know it - cavernous malformation, CCM, cavernoma, cavernous angioma - find information, opportunities, and hope here.

Click to read 20 Questions Answered

Statement from Recursion regarding REC-994 Trial

Recursion's message to our patients regarding the discontinuation of the REC-994 trial:  We have difficult news to share today. Recursion has made the decision to discontinue the SYCAMORE trial of REC-994, a treatment for Symptomatic Cerebral Cavernous Malformation. We understand this news may...

More

What is cavernous malformation?

Cavernous malformation (CCM) is a blood vessel disorder of the brain and spinal cord. CCM can lead to strokes, seizures, and other neurological damage. Surgery is the only current treatment. CCM affects more than 3 million children and adults worldwide.

More

Our Story

When we were founded in 2002, there was a void of cavernous malformation (CCM) research and information. Over the last 20 years, we have seized opportunities to bring scientists, patients, doctors, and industry partners together to advance a cure for CCM. Our work has driven research breakthroughs and improved patient care. We now have promising treatments just under five years away. We will persevere until we have a permanent cure for CCM – available, accessible, and affordable for all.

More

Get Involved

More Ways to Get Involved

OSZAR »